Twist Bioscience Corp DEF 14A: Executive Compensation Details

TL;DR

Twist Bioscience DEF 14A out: Executive pay details for FY24 are in, check equity award valuations.

AI Summary

Twist Bioscience Corp filed a DEF 14A on January 6, 2025, detailing executive compensation for the fiscal year ending September 30, 2024. The filing includes information on the fair value of equity awards granted, outstanding and unvested awards, and changes in fair value for prior year awards. Specific dollar amounts and dates related to these compensation elements are provided within the detailed tables.

Why It Matters

This filing provides transparency into how Twist Bioscience compensates its top executives, which can influence investor perception and executive decision-making.

Risk Assessment

Risk Level: medium — DEF 14A filings are routine disclosures of executive compensation and corporate governance, but can sometimes reveal changes or issues that impact stock price.

Key Numbers

• 0930 — Fiscal Year End (Indicates the end of the reporting period for financial data, including executive compensation.)

Key Players & Entities

• Twist Bioscience Corp (company) — Filer of the DEF 14A
• 0001581280 (company) — Central Index Key for Twist Bioscience Corp
• 20250106 (date) — Filing date of the DEF 14A
• 2024-09-30 (date) — Fiscal year end for compensation data
• 2023-09-30 (date) — Prior fiscal year end for compensation data

FAQ

Key Financial Figures

• $25,000 — eed to pay the Proxy Solicitor a fee of $25,000, plus customary out-of-pocket expenses

Filing Documents

• twst-20250106.htm (DEF 14A) — 1831KB
• twst-20250106_g1.jpg (GRAPHIC) — 10KB
• twst-20250106_g2.jpg (GRAPHIC) — 1KB
• twst-20250106_g3.jpg (GRAPHIC) — 22KB
• twst-20250106_g4.jpg (GRAPHIC) — 26KB
• twst-20250106_g5.jpg (GRAPHIC) — 67KB
• twst-20250106_g6.jpg (GRAPHIC) — 255KB
• twst-20250106_g7.jpg (GRAPHIC) — 177KB
• twst-20250106_g8.jpg (GRAPHIC) — 172KB
• twst-20250106_g9.jpg (GRAPHIC) — 526KB
• 0001628280-25-000641.txt ( ) — 5535KB
• twst-20250106.xsd (EX-101.SCH) — 2KB
• twst-20250106_def.xml (EX-101.DEF) — 2KB
• twst-20250106_lab.xml (EX-101.LAB) — 3KB
• twst-20250106_pre.xml (EX-101.PRE) — 1KB
• twst-20250106_htm.xml (XML) — 152KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 22 Compensation Discussion and Analysis 22 Compensation Committee Interlocks and Insider Participation 43 Summary Compensation Table 44 Grants of Plan-Based Awards in Fiscal 202 3 46 Outstanding equity awards as of September 30, 202 3 47 Option Exercises and Stock Vested in Fiscal Year 202 3 51 Equity Compensation Plan Information 51 Employment Agreements 51 Potential Payments upon Termination or Change in Control 52 Pay Ratio Disclosure 55 Pay Versus Performance 55

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 61 PROPOSAL 2–NON-BINDING, ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS 64 Vote Required 64 PROPOSAL 3–RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 65 Principal Accountant Fees and Services 65 Pre-Approval Policy 65 Vote Required 65 PROPOSAL 4 - APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2018 EQUITY INCENTIVE PLAN 66 Vote Required 77 i TABLE OF CONTENTS PROPOSAL 5 - APPROVAL OF AN AMENDMENT TO THE COMPANY'S CHARTER TO INCREASE THE NUMBER OF AUTHORIZED SHARES 78 Vote Required 79 PROPOSAL 6 - APPROVAL OF AN AMENDMENT TO THE CHARTER TO PROVIDE FOR OFFICER EXCULPATION 79 Vote Required 80 WHERE YOU CAN FIND MORE INFORMATION 81 FORM 10-K 81 OTHER MATTERS 81 ii TABLE OF CONTENTS TWIST BIOSCIENCE CORPORATION 681 Gateway Boulevard South San Francisco, California 94080 PROXY STATEMENT FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD AT 7:00 AM PACIFIC STANDARD TIME ON FEBRUARY 5, 2025 The board of directors (the " Board ") of Twist Bioscience Corporation, a Delaware corporation (the " Company ," " Twist ," " we ," " us " and " our "), is soliciting your proxy to vote at the 2025 annual meeting of stockholders (the " Annual Meeting ") of the Company to be held exclusively via live audiocast at www.virtualshareholdermeeting.com/TWST2025 on February 5, 2025, at 7:00 am Pacific Standard Time, including at any adjournment(s) or postponement(s) of the Annual Meeting. You are encouraged to log in to the website above before the Annual Meeting begins. Online check-in will be available approximately 15 minutes before the meeting starts. If you encounter any difficulties accessing or participating in the Annual Meeting through the meeting website, please call the support team at the numbers listed on the website log-in screen. We mailed copies of the proxy materials, which include

View Full Filing

View this DEF 14A filing on SEC EDGAR